Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
102
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Prognostic Factors and Outcomes in Advanced Stage Lung Cancer Patients with COVID-19 Omicron Variant Infection

Zhimei Zhao1 Department of Oncology, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao City, People’s Republic of ChinaView further author information
,
Xiang Han1 Department of Oncology, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao City, People’s Republic of ChinaView further author information
,
Yunhong You1 Department of Oncology, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao City, People’s Republic of ChinaView further author information
,
Jiankang Zhang2 Department of Medicine, Qingdao Medical College, Qingdao University, Qingdao City, People’s Republic of ChinaView further author information
,
Keke Nie1 Department of Oncology, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao City, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
&
Youxin Ji1 Department of Oncology, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao City, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-2303-8784View further author information
ORCID Icon
Pages 5947-5953 | Received 24 Aug 2023, Accepted 13 Dec 2023, Published online: 15 Dec 2023

References

  • Hadj Hassine I. Covid-19 vaccines and variants of concern: a review. Rev Med Virol. 2022;32(4). doi:10.1002/rmv.2313
  • Zhu -F-F, Gu -B-B, Jin Y-J, et al. Risk Factors for Radiological Progression Within Admissive One Week in the Hospitalized COVID-19 Omicron Variant-Infected Patients. Infect Drug Resist. 2022;15:7127–7137. doi:10.2147/idr.s388696
  • Guarnera A, Santini E, Podda P. COVID-19 Pneumonia and Lung Cancer: a Challenge for the Radiologist Review of the Main Radiological Features, Differential Diagnosis and Overlapping Pathologies. Tomography. 2022;8:513–528. doi:10.3390/tomography8010041
  • Wang QQ, Berger NA, Xu R. Analyses of Risk, Racial Disparity, and Outcomes among US Patients with Cancer and COVID-19 Infection. JAMA Oncol. 2021;7(2):220–227. doi:10.1001/jamaoncol.2020.6178
  • Rogado J, Pangua C, Serrano-Montero G, et al. Covid-19 and lung cancer: a greater fatality rate? Lung Cancer. 2020;146:19–22. doi:10.1016/j.lungcan.2020.05.034
  • Kasymjanova G, Anwar A, Cohen V, et al. The impact of COVID-19 on the diagnosis and treatment of lung cancer at a Canadian academic center: a retrospective chart review. Curr Oncol. 2021;28(6):4247–4255. doi:10.3390/curroncol28060360
  • Greenberg A, Anand G, Sinclair G. Lung Cancer Treatment in COVID-19–Positive Patients: guidelines and Gestalt. JCO Oncol Pract. 2020;16(9):615–617. doi:10.1200/op.20.00511
  • Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021;9. doi:10.1136/jitc-2020-002266
  • N. Cancer Institute, Common Terminology Criteria for Adverse Events (CTCAE) Common Terminology Criteria for Adverse Events (CTCAE) 5.0; 2017. Available from: https://www.meddra.org/. Accessed December 14, 2023.
  • Bazargan M, Elahi R, Esmaeilzadeh A. OMICRON: virology, immunopathogenesis, and laboratory diagnosis. J Gene Med. 2022;24(7):1. doi:10.1002/jgm.3435
  • Ying-Hui J, Qing-Yuan Z, Zhi-Yong P, et al. Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version). Med J Chinese People’s Lib Army. 2020;45:1003–1029. doi:10.11855/j.issn.0577-7402.2020.10.01
  • Thompson JA, Schneider BJ, Brahmer J, Management of Toxicities, NCCN Guidel. 2.2022; 2022. Available from: https://www.nccn.org/professionals/physician_gls/pdf/immunotherapy.pdf. Accessed December 14, 2023.
  • Verma G. Immunomodulatory approaches in managing lung inflammation in COVID ‐ 19: a double ‐ edge sword. Immunity Inflammation Dis. 2023:1–15. doi:10.1002/iid3.1020
  • Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. doi:10.1016/S1470-2045(20)30096-6
  • Horn L, Garassino M. COVID-19 in patients with cancer: managing a pandemic within a pandemic. Nat Rev Clin Oncol. 2021;18(1):18–19. doi:10.1038/s41571-020-00441-5
  • Che K, Hong C, He Y, Peng D, Zeng Z. Association of immune-related adverse events with COVID-19 pneumonia in lung cancer patients receiving immune checkpoint inhibitors: a cross-sectional study in China. BMC cancer. 2023;1–8.
  • Catania C, Stati V, Spitaleri G. Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer. Tumori. 2021;107(3):267–269. doi:10.1177/0300891620951863
  • Dingemans AMC, Soo RA, Jazieh AR, et al. Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic. J Thorac Oncol. 2020;15(7):1119–1136. doi:10.1016/j.jtho.2020.05.001
  • Zhang H, Quek K, Chen R, et al. Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer. J Cancer. 2020;11(18):5289–5292. doi:10.7150/jca.49462
  • Luo J, Rizvi H, Preeshagul IR, et al. COVID-19 in patients with lung cancer. Ann Oncol. 2020;31(10):1386–1396. doi:10.1016/j.annonc.2020.06.007
  • Peixoto D, Callia JPB, Bittencourt MS, et al. Clinical presentation and in-hospital prognosis of lung cancer patients presenting with suspected and confirmed COVID-19. Brazilian J Med Biol Res. 2022;55:1–7. doi:10.1590/1414-431X2022e12140

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.